Related Experiment Videos
Identifying potential tumor markers and antigens by database mining and rapid expression screening.
1Duke University Medical Center, Durham, North Carolina 27710, USA.
Genome Research
|September 14, 2000
Summary
Identifying novel brain tumor antigens is crucial for cancer therapy. This study combined database mining with fluorescent-PCR expression comparison (F-PEC) to discover potential glioblastoma multiforme tumor markers.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Genes specifically expressed in malignant tissues offer potential as therapeutic targets but are challenging to identify for most cancers.
- Public databases contain information on RNA transcripts uniquely expressed in transformed tissues, requiring verification and expression profiling for clinical utility.
Purpose of the Study:
- To evaluate a novel approach for locating candidate brain tumor antigens by combining database mining with rapid screening.
- To identify potential therapeutic targets for glioblastoma multiforme (GBM).
Main Methods:
- Mined the Cancer Genome Anatomy Project (CGAP) database for genes highly expressed in glioblastoma multiforme.
- Employed fluorescent-PCR expression comparison (F-PEC) for rapid screening of candidate genes.
- Conducted further expression profiling to validate identified genes.
Main Results:
- Thirteen genes highly expressed in glioblastoma multiforme were identified through database mining.
- Seven of the thirteen mined genes demonstrated potential as tumor markers or antigens following expression profiling.
- The combined approach proved effective in locating and evaluating candidate tumor antigens.
Conclusions:
- Database mining coupled with F-PEC is a viable strategy for discovering novel cancer-specific genes.
- This method can accelerate the identification and validation of potential therapeutic targets and biomarkers for glioblastoma multiforme and other cancers.